N-1-carboxyalkyl derivatives of LSD

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5843682
SERIAL NO

08560871

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel derivatives of LSD having the formula ##STR1## wherein R.sub.1 is an alkyl, cycloalkyl or aryl group having 1 to 10 carbon atoms, preferably an alkyl group having 1 carbon atom; R.sub.2 is a bond or ##STR2## wherein R.sub.3 is alkyl, cycloalkyl or aryl group having 2 to 10 carbon atoms, preferably an alkyl group having 2 or 5 carbon atoms; Z is an immunogenic carrier substance, an enzyme donor polypeptide or a label selected from the group consisting of an enzyme, a substance having fluorescent or luminescent properties and a radioactive substance; and n is 1 to p where p equals MW of Z/1000. The derivatives include maleimide conjugates of an immunogenic poly(amino acid), an enzyme donor polypeptide or a labeling substance such as an enzyme, a fluorescent substance or a radioactive substance. Novel activated hapten intermediates useful in the preparation of the conjugates and methods for synthesis of the hapten intermediates and their conjugate derivatives are also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ROCHE DIABETES CARE INC9115 HAGUE ROAD INDIANAPOLIS IN 46250

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Davoudzaheh, David Pleasanton, CA 1 5
Rouhani, Riaz Concord, CA 10 44
Sigler, Gerald F Carmel, IN 37 911

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation